Follow
Paul T. Henderson
Paul T. Henderson
Associate Professor, UC Davis
Verified email at ucdavis.edu
Title
Cited by
Cited by
Year
Long-distance charge transport in duplex DNA: the phonon-assisted polaron-like hopping mechanism
PT Henderson, D Jones, G Hampikian, Y Kan, GB Schuster
Proceedings of the National Academy of Sciences 96 (15), 8353-8358, 1999
7111999
In vivo release from a drug delivery MEMS device
Y Li, RS Shawgo, B Tyler, PT Henderson, JS Vogel, A Rosenberg, ...
Journal of Controlled Release 100 (2), 211-219, 2004
2982004
The aflatoxin B1 formamidopyrimidine adduct plays a major role in causing the types of mutations observed in human hepatocellular carcinoma
ME Smela, ML Hamm, PT Henderson, CM Harris, TM Harris, ...
Proceedings of the National Academy of Sciences 99 (10), 6655-6660, 2002
2502002
The hydantoin lesions formed from oxidation of 7, 8-dihydro-8-oxoguanine are potent sources of replication errors in vivo
PT Henderson, JC Delaney, JG Muller, WL Neeley, SR Tannenbaum, ...
Biochemistry 42 (31), 9257-9262, 2003
2492003
Oxidation of 7, 8-dihydro-8-oxoguanine affords lesions that are potent sources of replication errors in vivo
PT Henderson, JC Delaney, F Gu, SR Tannenbaum, JM Essigmann
Biochemistry 41 (3), 914-921, 2002
1762002
Different apolipoproteins impact nanolipoprotein particle formation
BA Chromy, E Arroyo, CD Blanchette, G Bench, H Benner, JA Cappuccio, ...
Journal of the American Chemical Society 129 (46), 14348-14354, 2007
1232007
Kinetics of carboplatin− DNA binding in genomic DNA and bladder cancer cells as determined by accelerator mass spectrometry
SS Hah, KM Stivers, RW de Vere White, PT Henderson
Chemical research in toxicology 19 (5), 622-626, 2006
1172006
Detection of Adriamycin–DNA adducts by accelerator mass spectrometry at clinically relevant Adriamycin concentrations
KE Coldwell, SM Cutts, TJ Ognibene, PT Henderson, DR Phillips
Nucleic acids research 36 (16), e100, 2008
1012008
High-fidelity in vivo replication of DNA base shape mimics without Watson–Crick hydrogen bonds
JC Delaney, PT Henderson, SA Helquist, JC Morales, JM Essigmann, ...
Proceedings of the National Academy of Sciences 100 (8), 4469-4473, 2003
992003
Evaluation of microdosing strategies for studies in preclinical drug development: demonstration of linear pharmacokinetics in dogs of a nucleoside analog over a 50-fold dose range
P Sandhu, JS Vogel, MJ Rose, EA Ubick, JE Brunner, MA Wallace, ...
Drug metabolism and disposition 32 (11), 1254-1259, 2004
882004
Radical cation transport and reaction in RNA/DNA hybrid duplexes: effect of global structure on reactivity
V Sartor, PT Henderson, GB Schuster
Journal of the American Chemical Society 121 (48), 11027-11033, 1999
801999
Human endonuclease III acts preferentially on DNA damage opposite guanine residues in DNA
L Eide, L Luna, EC Gustad, PT Henderson, JM Essigmann, B Demple, ...
Biochemistry 40 (22), 6653-6659, 2001
782001
In vivo bypass efficiencies and mutational signatures of the guanine oxidation products 2-aminoimidazolone and 5-guanidino-4-nitroimidazole
WL Neeley, JC Delaney, PT Henderson, JM Essigmann
Journal of Biological Chemistry 279 (42), 43568-43573, 2004
732004
Characterization of oxaliplatin− DNA adduct formation in DNA and differentiation of cancer cell drug sensitivity at microdose concentrations
SS Hah, RA Sumbad, RW de Vere White, KW Turteltaub, PT Henderson
Chemical research in toxicology 20 (12), 1745-1751, 2007
712007
DNA adducts from anticancer drugs as candidate predictive markers for precision medicine
A Stornetta, M Zimmermann, GD Cimino, PT Henderson, SJ Sturla
Chemical research in toxicology 30 (1), 388-409, 2017
692017
Urea lesion formation in DNA as a consequence of 7, 8-dihydro-8-oxoguanine oxidation and hydrolysis provides a potent source of point mutations
PT Henderson, WL Neeley, JC Delaney, F Gu, JC Niles, SS Hah, ...
Chemical research in toxicology 18 (1), 12-18, 2005
642005
Measurement of 7, 8-dihydro-8-oxo-2′-deoxyguanosine metabolism in MCF-7 cells at low concentrations using accelerator mass spectrometry
SS Hah, JM Mundt, HM Kim, RA Sumbad, KW Turteltaub, PT Henderson
Proceedings of the National Academy of Sciences 104 (27), 11203-11208, 2007
622007
Personalized medicine for targeted and platinum-based chemotherapy of lung and bladder cancer
GD Cimino, C Pan, PT Henderson
Bioanalysis 5 (3), 369-391, 2013
602013
Sources of extracellular, oxidatively-modified DNA lesions: implications for their measurement in urine
MS Cooke, PT Henderson, MD Evans
Journal of Clinical Biochemistry and Nutrition 45 (3), 255-270, 2009
572009
Cell-free expression for nanolipoprotein particles: building a high-throughput membrane protein solubility platform
JA Cappuccio, AK Hinz, EA Kuhn, JE Fletcher, ES Arroyo, PT Henderson, ...
High Throughput Protein Expression and Purification: Methods and Protocols …, 2009
552009
The system can't perform the operation now. Try again later.
Articles 1–20